TIBCS 2025

E-poster

E-poster No. / 壁報編號 Category / 主題分類 Title / 題目 First Author / 第一作者 Audio / 音訊檔
B01
Basic Research Single-cell analysis in diverse mechanisms of CDK4/6 inhibitors resistance in ER-positive breast cancers Yoshie Kobayashi
B02
Basic Research Exploring the Anti-Breast Cancer Potential of Ivacaftor: Mechnistic Insights into Apoptosis Induction and Cell Cycle Arrest 林金瑤
B03
Basic Research Intratumoral Fusobacterium Nucleatum Mediates Breast Cancer Cell Growth by Activating Interleukin-1β 張群明
B04
Basic Research Dual Metabolic Reprogramming in Metastatic Breast Cancer: The Critical Role of ANT2 in Supporting Energy Homeostasis and Progression Chia-Jung Li
B05
Basic Research Investigating the molecular mechanism in which GRK6 promotes the metastatic progression of triple-negative breast cancer via regulating PI3K/Akt/mTOR activity and autophagy formation and the related applications in translational medicine Hui-Yu Lin
B06
Basic Research SHMT2 Promotes Breast Cancer Metastasis through Metabolic Reprogramming and EMT Activation Yen-Dun Tony Tzeng
B07
Basic Research Bromelain Reduces Doxorubicin-Induced Cardiac Toxicity: A Potential Adjuvant in Oncology Care Asdi Wihandono
B08
Basic Research ABCA12 Drives Methotrexate Resistance in Breast Cancer: Insights from Multi-Omics and AI-Based Structure Prediction Yu-Chieh Tsai
B09
Basic Research MIRAY1 (Multi Institutional bReast cAncer Young team No.1): Fostering Next generation Professionals and Networks in Breast Cancer in Japan Mai Kitazawa
B11
Basic Research CIK-Based Immunotherapy for Cutaneous Metastases Breast Cancer: Translational Insights from Preclinical Immune Profiling 羅啟文
B12
Basic Research "Cyanidin-3-Glucoside Delays Mammary Tumor Progression via Akt Pathway Suppression in a Spontaneous Mouse Model" Hui-Ju Tsou
B13
Basic Research Spatial transcriptomics reveals clone-specific features of primary and metastatic tumors in triple-negative breast cancer Chih-Chiang Hung
B14
Basic Research Epigenetic inhibition of PLK1 by Luteolin-7-glucoside suppresses Estrogen receptor-positive breast cancer progression and proliferation. Joseph Lin
B15
Basic Research Novel HER2 activity linked to therapy resistance and brain metastasis Kieu-Thanh Huynh
B16
Basic Research Targeting the EZH2–PD-L1 Axis: Capsanthin Impairs PD-L1 Glycosylation and Inhibits Migratory Potential in Triple-Negative Breast Cancer Brain Metastases Yung-Luen Yu
B17
Basic Research Melittin Demonstrates Cytotoxic and Anti-Invasive Effects Against Aromatase Inhibitor-Resistant Breast Cancer Cells Through Mitogen-Activated Protein Kinase Pathway Inhibition Min-Hua Wu
B18
Basic Research Adipocyte-Derived SERPINE1 Drives Obesity-Associated Breast Cancer Progression: Integrative Transcriptomic and Functional Analyses Kian-Hwee, Chong
B19
Basic Research Subtype-Specific Epigenetic Remodeling in Breast Cancer Under Hormonal Stimulation An-Chieh Feng
B20
Basic Research The Role of miRNAs in breast cancer across distinct subtypes via microarray analysis Chi-Cheng Huang
B21
Basic Research Toosendanin inhibits the metastatic progression of triple-negative breast cancer by abrogating ADORA2A-driven neurogenesis ZHANG JUAN
B22
Basic Research SCD1-driven lipid metabolic reprogramming confers resistance to HER2-targeted therapies in breast cancer MENG-XIA SU
B23
Basic Research Oncoplastic Breast Surgery (OBS) in Breast Cancer Care: A Review of Clinical, Oncological and Patient-Centred Outcomes in a Single Tertiary Centre Yi Ping Lim
B24
Basic Research Sacituzumab govitecan in HR-positive/HER2-negative breast cancer cells with resistance to PI3K or AKT inhibitors Wei-Pang Chung
B25
Basic Research Evaluation of Metformin as a Novel Therapeutic Agent for Aromatase Inhibitor-Resistant Estrogen Receptor-Positive Breast Cancer: An In Vitro Efficacy Study Yu-Fen Wang
B26
Basic Research Disrupting DDB2–DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity Yu-Hao He, Ph.D.
B27
Basic Research Preliminary spatial transcriptomic analysis for invasive lobular carcinoma Chi-Cheng Huang
B28
Basic Research Tartrate-resistant acid phosphatase 5 regulates the metabolic flexibility of macrophages in the tumor microenvironment, thereby influencing their functional fate and modulating tumor growth. 陳昱光
B29
Basic Research Abnormal KIF11 induction is associated with poor prognosis in ER- positive breast cancers Seungpill Jung
B30
Basic Research The immune modulation and synergistic effect with immunotherapy of astragalus polysaccharides in breast cancer Ming-Shen Dai
B31
Basic Research Apple polyphenol phloretin inhibits type II glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer Han-Sheng Chang
C01
Clinical Research Multi-Model Ensemble Learning to Maximize Sensitivity and Reduce Diagnostic Risk in Breast Ultrasound AI Hsiang wei Huang
C02
Clinical Research Circulating serum metabolites as biomarkers for the early detection of breast cancer Kyunghwan Kim
C03
Clinical Research Clinical Relevance of PIK3CA Mutations in Modulating CDK4/6 Inhibitor Efficacy in HR+/HER2− Advanced Breast Cancer Sheng-Fan Wang
C04
Clinical Research A clinicopathological analysis of a mini case series of false-negative fibroadenomas and microcalcifications leading to missed diagnosis of occult breast cancer and the development of metastatic lesions. Min-Yu Tsai
C05
Clinical Research Discrepancy Between Clipped and Sentinel Lymph Nodes in Neoadjuvant Breast Cancer Patients with Pre-treatment Nodal Metastasis: A Single-Center Analysis Using SPECT/CT for Sentinel Node Detection Yen-Ya Chen
C06
Clinical Research Holistic Needs Assessment for Hospitalized Patients with Breast Cancer: A Prospective Cross-Sectional Study Shin-Ling Wen
C07
Case Report Sacituzumab Govitecan for Leptomeningeal Metastases in Triple-Negative Breast Cancer with Glycogen-Rich Clear Cell Feature: A Very Rare Case Report Yun-Chih Lo
C08
Case Report Case series of long-term survivors in HER2-positive metastatic breast cancer treated with prolonged Trastuzumab: Clinical experience from a single institution Shih-Min, Pai
C09
Case Report Ductal carcinoma in situ in the male breast: A case report Chia-Ming Lin
C10
Clinical Research The impact of tumor-specific DNA damage and repair signature on chemotherapy outcome in triple-negative breast cancer Chao-Ming Hung
C11
Clinical Research Feasibility of Local Anesthesia in Surgery for Early-Stage Breast Cancer Dong Hyeon Oh
C12
Clinical Research Risk of radiation pneumonitis following concurrent administration of capecitabine with radiotherapy in HER2-negative breast cancer Jeongshim Lee
C13
Clinical Research From AI to Single-Cell and Multi-Omics: RAC1 as a Prognostic and Therapeutic Target in Breast Cancer Oncometabolism and Immunomodulation 林宏昱
C14
Clinical Research AI-Powered Structural Modeling and Multi-Omics Integration Unveil DNM1L/DRP1 Therapeutic Vulnerabilities and Prognostic Significance in Breast Cancer Yi-Heng Chen
C16
Clinical Research Influence of Age on Physicians’ Decision on Offering Chemotherapy to Breast Cancer Patients with Positive Lymph Nodes Fang-Ju Hsueh
C18
Case Report Radiation-Induced Undifferentiated Pleomorphic Sarcoma After Standard-Dose Radiotherapy for Breast Cancer: A Case Report PoHeng Lin
C19
Clinical Research Axillary Radiotherapy versus Axillary Lymph Node Dissection After Positive Sentinel Lymph Node in Taiwanese Patients with Breast Cancer : A Single Center Retrospective Study Chiung Hui Hsieh
C20
Clinical Research Real-world experience of oral combination metronomic chemotherapy in patients with metastatic breast cancer Jing-Jou Lo
C21
Clinical Research Divergent Trop-2 and Stable HER2 Expression in Matched Primary and Brain Metastatic Breast Cancers Tsai Li-Wei
C22
Clinical Research Associated Clinicodemographic Factors For Two-Year Recurrence Of Locally Advanced Breast Cancer : A Study In A Tertiary Hospital Desak Gede Agung Pramesti Devi
C23
Clinical Research Interval Between Neoadjuvant Chemotherapy and Surgery Has No Impact on Breast Cancer Outcomes Chih-Hao Huang
C24
Clinical Research Use of pre-treatment MRI-derived radiomics to predict the final treatment response to neoadjuvant chemotherapy in breast cancer patients: a preliminary study Jane Wang
C25
Clinical Research Vacuum-assisted excision as a surgical-sparing strategy for benign breast lesions: clinical and economic insights Aireen Grace Castillon
C26
Clinical Research Stricter risk stratification is essential for intraoperative radiotherapy alone: long-term evidence from a Taiwanese breast cancer cohort Yu-Chen Hsu
C27
Clinical Research Clinical efficacy of CDK4/6 inhibitor rechallenge after progression on prior CDK4/6 inhibitor treatment in HR+/HER2− metastatic breast cancer (MBC): a systematic review and meta-analysis Shuhan Chang
C28
Clinical Research Clinical significance of HER2‑low expression in non-metastatic breast cancer: a nationwide study from the Taiwan Cancer Registry Hsin-Ya Huang
C29
Clinical Research Dental prosthesis needs among breast cancer survivors: A Korean nationwide cross-sectional study with subgroup analysis by menopausal status at diagnosis Hee Yeon Kim
C30
Clinical Research Clinical outcomes of lobular carcinoma in situ (LCIS) : risk of invasive cancer development Doyoun Woen
C31
Clinical Research Comparative Analysis of Overall Survival by TNM Stage in Invasive Lobular and Ductal Carcinoma YOUNG-WON LEE
C32
Clinical Research Single-Port Three Dimensional Scope-Assisted Mastectomy: Learning Curve, Risk Factors for Complications, and Cosmetic Outcomes in 148 Breast Cancer Patients Yao-Chung Wu
C33
Clinical Research Risk factors and germline testing in Asian American/Pacific Islander women with breast cancer Jennifer Tseng
C34
Case Report Encapsulated Papillary Carcinoma of the Breast: Diagnostic Challenges and the Importance of Comprehensive Pathology Chi-En Hung
C35
Case Report Navigating the Complexities of Breast Neuroendocrine Neoplasms: A Case Report and Review Chi-En Hung
C36
Clinical Research Impact of psychiatric disorders on metastatic breast cancer survival: the critical role of supportive psychiatric management Cho-Hao Lee
C37
Clinical Research Effectiveness and safety of ribociclib versus palbociclib as first-line therapy in metastatic breast cancer: a target trial emulation using real-world data Cho-Hao, Lee
C38
Clinical Research The adoption rate and management of treatment-emergent adverse event during adjuvant abemaciclib treatment in Japanese women with high-risk HR+HER2- early breast cancer KAORI TANE
C39
Clinical Research Oncologic safety of breast-conserving surgery compared to total mastectomy in very young women (≤35 years) Young-Jin Lee
C40
Case Report Effectiveness of chemotherapy in locally advanced breast cancer (LABC):case report DASHZEVEG TUGULDUR
C41
Case Report Novel use of Negative Pressure Wound Therapy (NPWT) in Aesthetic Flat Closure of Mastectomy for Breast Cancer and Gigantomastia Jeffrey Hing
C42
Case Report Orbital metastasis from breast cancer: A case report Saranzaya Damdin
C43
Case Report Unexpected contralateral axillary lymph node metastasis without ipsilateral involvement in triple-negative breast cancer : A case report Zhi-Jie Hong
C44
Clinical Research Re-Evaluation of Sentinel Lymph Node Biopsy in Patients Initially Diagnosed with DCIS on Core Needle Biopsy but Found to Have Invasive Carcinoma on Final Pathology After Breast-Conserving Surgery Sang Yull Kang
C45
Case Report Case Report: Grade 2 Arthritis Induced by Pembrolizumab in a 41-Year-Old Woman with Triple-Negative Breast Cancer YU MENG CLAIRE LIN
C46
Clinical Research Diagnostic Performance of AI-CAD for Microcalcifications in Mammography Wen-Pei Wu
C47
Clinical Research Improving Diagnostic Accuracy of Suspicious Breast Microcalcifications: Combining Wire Localization with Vacuum-Assisted Breast Biopsy An-Chieh Feng
C48
Clinical Research Real-World Treatment Patterns and Effectiveness in Patients With Advanced Hormone-Positive Breast Cancer Kai-Cheng Chang
C49
Clinical Research Deep learning using preoperative breast MRI for predicting axillary lymph node metastasis in early-stage breast cancer Wen-Pei Wu
C50
Clinical Research Early Oncologic Outcomes of Robot-Assisted Versus Conventional Nipple-Sparing Mastectomy: A Propensity Score Matching Analysis Seung Ah Lee
C51
Clinical Research The effect of chemotherapy on cognitive function impairment in patients with breast cancer Ting Ling-Wen
C52
Clinical Research Improved Survival with Breast-Conserving Surgery Followed by Radiotherapy Compared to Total Mastectomy in Early-Stage Breast Cancer: A Single-Center Cohort Study Kibum Kim
C53
Clinical Research Real-World Outcomes of TS-1 as Adjuvant Therapy in Hormone Receptor–Positive, HER2-Negative Early Breast Cancer: A Single-Center Experience Yu-wen Weng
C54
Clinical Research Japanese Experience with Trastuzumab Deruxtecan Re-administration Following Interstitial Lung Disease Kyoko Goda
C55
Clinical Research A absorbable polysaccharide powder, HaemoCer, reducing post-operative drainage output, a retrospectively study 朱士偉 Shih-Wei Chu
C56
Clinical Research Evaluation of a Novel Diagnostic Kit Using the Semi-Dry Dot-Blot Method with an Automated Reader for Detecting Breast Cancer Metastases in Sentinel Lymph Nodes: A Combined Analysis of Two Multicenter Prospective Studies in Japan Ryota Otsubo
C57
Clinical Research The characteristics associated with ductal carcinoma in situ upgrading to carcinoma 趙梧博
C58
Clinical Research Xenogeneic platelet-rich plasma lotion for the prevention of acute radiation dermatitis in patients with breast cancer receiving radiotherapy Shin-Ting Chen
C59
Case Report Case report of concurrent Nab-paclitaxel and Atezolizumab combined with radiation therapy for subclavicular lymph node recurrence Masahiro Yoshida
C60
Clinical Research Immunogenic Effect of PIK3CA Mutations in Breast Cancer: Implications for Neoantigens, HLA Types, and Immune Microenvironment Chen, Hsing-wu
C61
Case Report Metastatic appendiceal adenocarcinoma presenting as a breast mass : a rare case report Huang Yi Ta
C62
Clinical Research HER-2 conversion after neoadjuvant therapy in 2 cases Luo-Hsin, Wu
C63
Clinical Research The significance of HER2 1+ expression on late recurrence-free survival after 5 years in ER-, HER2- breast cancer Yeonjoo
C64
Clinical Research Real-World Effectiveness and Safety of Neoadjuvant Pembrolizumab plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: Updated Data from a Single-Center Taiwanese Cohort Han Fang Cheng
C65
Case Report Synchronous metaplastic carcinoma and invasive ductal carcinoma in ipsilateral breast: a rare case report 黃星華
C66
Case Report Primary invasive ductal carcinoma of breast arising in ectopic breast tissue of the chest wall 黃星華
C67
Clinical Research Discovery of BRCA Founder Variants in Taiwanese Cancer Patients: Clinical Actionability and Population Screening Implications from 84-Gene Panel Analysis Peng-Yu Chen
C68
Case Report A case report of hormone-positive breast cancer, relapsed after 17 years, presented as bilateral lungs and bone metastasis Ching-Hao Yen, M.D
C69
Clinical Research Clinical Outcomes of Single Versus Double Hormone-Receptor Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Retrospective Cohort Study 游啓昌
C70
Clinical Research AI-Powered Precision Oncology: Integrating Fine-Tuned GPT with LINE for Enhanced Breast Cancer Patient Support and Case Management Lee Pei Yi
C71
Clinical Research A Comparison of Outcomes in Early Triple Negative Breast Cancer Treated with Pembrolizumab–Chemotherapy and Chemotherapy: A Single Center Experience Cheng-Lin Tsai
C72
Clinical Research What We Learned from AJCC 8th Edition Cancer Staging System for Our Breast Cancer Patients (2005–2021) Ben-Long Yu
C73
Clinical Research Surgical outcomes of volume replacement using pulverized acellular dermal matrix after breast conserving surgery in early stage breast cancer HEEWON RYU
C74
Clinical Research Impact of screening on breast cancer management: A comparative analysis of stage distribution and treatment modalities in screen-detected versus symptom-detected cancers Johanna Frances Dompor
C75
Clinical Research Transcriptomic profiling of tumor-specific DNA damage and repair signatures across breast cancer subtypes Dong-Ying Wu
C76
Case Report Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma Zhi-Jie Hong
C77
Clinical Research Long-term Outcome of Slowly Proliferating Luminal Type ILC versus IDC 변단
C78
Clinical Research The prevalence of BRCA 1/2 mutation in high-risk early breast cancer patient cohort and the treatment outcomes – Wanfang Hospital experience Dai-Zhu Lin, M.D.
C79
Clinical Research Child Birth after Breast Cancer Treatment of Women in Their Childbearing Age in Taiwan Wan-Yu Huang
C80
Clinical Research Ki-67 expression as a primary biomarker for chemotherapy avoidance in early luminal-type breast cancer Hung-Hsun Chen
C81
Clinical Research Features of Breast Cancer Across Age Groups in a Japanese Hospital: Comparison with Global Trends Hitomi Mori
C82
Clinical Research Revisiting the Value of Routine Immunohistochemical Markers for Predicting Pathologic Response and Prognosis in Estrogen Receptor-Strong Positive and HER2 Negative Breast Cancer Su Min Lee
C83
Clinical Research Cohort Study on Adjuvant Treatment for Premenopausal HR positive/HER2 negative Breast Cancer Patients with 1-3 Positive Nodes PINGFU YANG
C84
Clinical Research Oncological outcome of occult residual nodal metastasis in post-neoadjuvant chemotherapy breast cancer Wai-shan Chung
C85
Clinical Research The Analysis of Immediate Breast Reconstruction After Mastectomy for Breast Cancer Patients – the Experiences in NCKUH from 2022 to 2024 Kuo-Ting Lee
C86
Clinical Research Mature B cell with the antigen presenting signature predicts pathologic complete response and survival in early Her2-positive breast cancer treated with neoadjuvant therapy Po-Han Lin
C87
Case Report Case Report: Lobular Breast Cancer in Hereditary Cancer Syndrome HOANG THU HANG
C88
Clinical Research Baseline bone mineral density and bone metabolism markers in hormone receptor-positive breast cancer patients undergoing aromatase inhibitor treatment: a preliminary report from a randomized controlled trial 蔡易臻
C89
Clinical Research Can we omit axillary surgery in T1 breast cancer? Taiwan multi-center real world data. Yu-Shuan Ho
C90
Case Report Delayed Ipsilateral DIEP Flap Reconstruction and Contralateral Breast-Conserving Surgery: A Case Report Batsukh.P
C91
Case Report A Rare Type of Breast Cancer - Adenoid Cystic Carcinoma of Breast: Case Report Yu-Ta Wu
C92
Clinical Research Real-World Outcomes of Ribociclib in HR+/HER2– Metastatic Breast Cancer: A Single-Center Retrospective Study from Southern Taiwan Shih-Yu Huang
C93
Clinical Research Age-informed real-world evidence reveals TP53 mutation confers resistance to CDK4/6 but not immune checkpoint inhibitors in ER-positive/HER2-negative breast cancer Masanori Oshi
C94
Clinical Research Association of GADD45A and favorable outcome in hormone positive breast cancer Jiun-I Lai
C95
Clinical Research Early Outcomes of Prepectoral Implant-Based Reconstruction Using GalaFLEX Mesh Ik-Hon, Ting
C96
Clinical Research The possible risk factors in triple-negative breast cancer: a retrospective cohort at Hsinchu MacKay Memorial Hospital Jui-Fan Chiang
C97
Clinical Research Association of statin use and mean heart dose with cardiovascular risk in breast cancer radiotherapy Tzu-Yu Lai
C98
Clinical Research Pembrolizumab in Early-Stage Triple-Negative Breast Cancer: Real-World Evidence from a Single-Center Retrospective Study 陳碩偉